Gelteq Limited is pursuing FDA regulatory approval for its products, establishing a Center of Excellence in Guangdong and completing palatability trials with Kemin.
1 report, 1 independent
Updated Jun 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Gelteq Limited is pursuing FDA regulatory approval for its products, establishing a Center of Excellence in Guangdong and completing palatability trials with Kemin.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- John Greaves served as VP of Specialty Crops for Kemin Industries, which participated in the Global Farmer Roundtable in 2013.Sub-event
Gelteq established a Center of Excellence in Guangdong and completed palatability trials with Kemin as it pursues FDA regulatory pathways.1 source
Keep exploring
The entities involved
-
Kemin Industries
American health and nutrition company
Nothing else this week.
- FDA
Related events
- FDA and Pfizer are seeking regulatory approval for their products.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- FDA approval enables commercial opportunity involving CBRE Group.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.